Skip to main content

Matrixyl

No sources yet

An index of captured practitioner sources, not a completed evidence summary. Unchecked figures and empty sections are omitted. See the library review status.

Source summary generated November 6, 2026; this date does not indicate completed review.

Tissue researchAliases: palmitoyl pentapeptide-4, Pal-KTTKS
Track your own protocol free →

Quotes from three independent practitioners, with their sources. Research context only.

What it is and how it works

From the published literature on Matrixyl; the papers are listed at the end. Research summary, not a recommendation.

What it is

Matrixyl is the trade name for palmitoyl pentapeptide-4 (Pal-KTTKS), a cosmetic ingredient made of five amino acids (lysine, threonine, threonine, lysine, serine) with a fatty acid (palmitic acid) attached to help it enter the outer skin. The five-amino-acid sequence was identified in 1993 as the smallest fragment of the type I procollagen precursor that switched on collagen production in cultured cells. A related product, Matrixyl 3000, pairs two other signal peptides (palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7); the papers below concern Pal-KTTKS and topical signal peptides as a class. It is a cosmetic ingredient, not a drug.

How it works

Pal-KTTKS is classed as a signal peptide, meaning a short fragment that mimics a piece of a broken-down skin protein and is read by skin cells as a cue to rebuild. In fibroblasts (the cells in the dermis that make the skin's support proteins) the KTTKS sequence increased production of type I and type III collagen and fibronectin, which are the main structural proteins of the skin's support layer. The attached palmitic acid made the peptide more stable and let it reach the upper skin layers in mouse-skin studies, though it did not pass fully through the skin. The proposed result is a thicker, more organised support layer and softer fine lines.

What it has been studied for

  • Fine lines and wrinkles in photoaged facial skin (human controlled trial)
  • Crow's feet wrinkles (small human randomized trial)
  • Collagen and fibronectin production by skin cells (cell studies)
  • Skin penetration and stability of topical peptides (lab studies)

Strength of the evidence

Human trialsA placebo-controlled split-face trial and a small randomized trial of topical creams have been published, both short and in limited groups of women, and most mechanism data come from cell studies.

What the literature reports on safety

The human trials reported that the topical peptide was well tolerated, with no notable irritation. It is regulated as a cosmetic ingredient rather than a drug, so it is not FDA approved for any medical use and has no premarket regulatory review. Reviews note that the clinical studies are small, short and often industry-sponsored, and that skin absorption limits how much reaches the dermis.

Key papers

  1. Topical peptides as cosmeceuticals (opens in a new tab)

    Review · Pai VV, Bhandari P, et al. · Indian Journal of Dermatology, Venereology and Leprology (2017) · PMID 27451932

    Reviewed topical peptides by class (signal, carrier and neurotransmitter-modulating) and noted that clinical evidence for efficacy was often weak and skin absorption often poor.

  2. Role of topical peptides in preventing or treating aged skin (opens in a new tab)

    Review · Gorouhi F, Maibach HI · International Journal of Cosmetic Science (2009) · PMID 19570099

    Grouped anti-ageing peptides into signal, enzyme-inhibitor, neurotransmitter-inhibitor and carrier peptides and reviewed the controlled studies of each, including palmitoyl pentapeptide.

  3. Peptides in Aesthetic Dermatology: Classification, Fibroblast-Centered Mechanisms, Delivery Technologies, and Clinical Evidence (opens in a new tab)

    Review · Yi KH, Kim HS, et al. · Life (Basel) (2026) · PMID 42942246

    Found that matrix-signalling peptides changed fibroblast behaviour in lab systems and that human trials showed wrinkle improvements, but many trials were small, short, industry-sponsored or used multi-ingredient products.

  4. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin (opens in a new tab)

    Randomized trial · Robinson LR, Fitzgerald NC, et al. · International Journal of Cosmetic Science (2005) · PMID 18492182

    In a 12-week double-blind, placebo-controlled split-face trial in 93 women, the moisturizer containing Pal-KTTKS reduced wrinkles and fine lines more than the plain moisturizer and was well tolerated.

  5. Double-blind, Randomized Trial on the Effectiveness of Acetylhexapeptide-3 Cream and Palmitoyl Pentapeptide-4 Cream for Crow's Feet (opens in a new tab)

    Randomized trial · Aruan RR, Hutabarat H, et al. · Journal of Clinical and Aesthetic Dermatology (2023) · PMID 36909866

    In 21 Indonesian women over eight weeks, the palmitoyl pentapeptide-4 cream showed better crow's-feet results than the argireline cream or placebo; the authors called it an initial study needing a larger sample.

  6. A pentapeptide from type I procollagen promotes extracellular matrix production (opens in a new tab)

    Lab (in vitro) · Katayama K, Armendariz-Borunda J, et al. · Journal of Biological Chemistry (1993) · PMID 8486721

    Identified Lys-Thr-Thr-Lys-Ser as the minimum fragment of the type I procollagen propeptide that stimulated collagen and fibronectin production in cultured connective-tissue cells.

  7. Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS) (opens in a new tab)

    Lab (in vitro) · Choi YL, Park EJ, et al. · Biomolecules & Therapeutics (2014) · PMID 25143811

    In hairless-mouse skin the palmitoylated peptide was more stable than plain KTTKS and reached the epidermis and dermis, but neither form passed fully through the skin.

Sources checked: PubMed/PMC (E-utilities esummary and abstracts on every PMID), written 2026-11-06.

No sources yet

None of the three teachers' sources we have indexed discuss Matrixyl yet. This page will fill in as sources are added.

Deeper guided audio lives on What Am I Appreciating Now (leaves this site, opens in a new tab). What Am I Appreciating Now is a separate site run by the same operator; it sells meditation and hypnosis sessions.

Disclaimer: for research purposes only

All content on this page is for research and educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any peptide or hormone protocol. You take responsibility for your own protocol.If your path includes peptides, you buy them yourself from an independent licensed provider through a member co-op; we take nothing. How independent access works.

Matrixyl — Hunter, Taylor, Bachmeyer | Reset Biology